Lipocine Inc.
LPCN
$3.09
-$0.16-4.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.48% | -18.27% | -204.64% | 180.32% | 27.69% |
| Total Depreciation and Amortization | -12.42% | 3.21% | 0.00% | 83.53% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.34% | 140.63% | 155.41% | 88.35% | -1,965.63% |
| Change in Net Operating Assets | -38.52% | 305.43% | -82.28% | 82.84% | -174.19% |
| Cash from Operations | -58.29% | 4.22% | -215.71% | 160.08% | -13.42% |
| Capital Expenditure | -- | -- | -- | 87.52% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.41% | 610.15% | -214.40% | -30.06% | -76.80% |
| Cash from Investing | -84.41% | 610.15% | -215.90% | -25.56% | -78.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 86.90% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.90% | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -179.68% | 194.32% | -215.77% | 236.05% | -173.24% |